Cargando…
Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy
BACKGROUND: The present study aims to evaluate dosimetric and clinical risk factors for the development of maxillary osteoradionecrosis (ORN) in head and neck adenoid cystic carcinoma (ACC) patients treated with carbon ion radiotherapy (CIRT). METHODS: Clinical data and treatment plans of ACC patien...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924362/ https://www.ncbi.nlm.nih.gov/pubmed/35311095 http://dx.doi.org/10.3389/fonc.2022.829502 |
_version_ | 1784669837465747456 |
---|---|
author | Vischioni, Barbara Russo, Stefania Meuli, Martino Bonora, Maria Ronchi, Sara Ingargiola, Rossana Camarda, Anna Maria Imparato, Sara Preda, Lorenzo Ciocca, Mario Molinelli, Silvia Orlandi, Ester |
author_facet | Vischioni, Barbara Russo, Stefania Meuli, Martino Bonora, Maria Ronchi, Sara Ingargiola, Rossana Camarda, Anna Maria Imparato, Sara Preda, Lorenzo Ciocca, Mario Molinelli, Silvia Orlandi, Ester |
author_sort | Vischioni, Barbara |
collection | PubMed |
description | BACKGROUND: The present study aims to evaluate dosimetric and clinical risk factors for the development of maxillary osteoradionecrosis (ORN) in head and neck adenoid cystic carcinoma (ACC) patients treated with carbon ion radiotherapy (CIRT). METHODS: Clinical data and treatment plans of ACC patients, consecutively treated from January 2013 to September 2016 within the phase II clinical trial CNAO S9/2012/C, were retrospectively reviewed. ORN and other treatment-related toxicity were graded according to the Common Terminology Criteria for Adverse Events (CTACE), version 4.0. The maxillary bone was contoured on the planning CT, and only patients receiving more than 10% of the prescription dose at their maxilla were considered for the analysis (67 patients). The volumes of maxilla receiving doses from 10 Gy (RBE) to 60 Gy (RBE) (V(D)), with an increment of 10 Gy (RBE), and additional clinical factors were correlated to the incidence of ORN with univariate analysis (Chi-square test). The logistic regression model was subsequently applied for multivariate analysis. Treatment plans calculated with a local effect model (LEM)-based optimization were recalculated with the modified microdosimetric kinetic model (MKM), and compared with literature data from the Japanese experience. RESULTS: The median time interval from the start of CIRT to ORN appearance was 24 months (range, 8–54 months). Maxillary ORN was observed in 11 patients (16.4%). Grade 1 ORN was observed in 2 patients (18.1%), G2 in 4 (36.3%), G3 in 4 (36.3%) and G4 in 1 (9.3%). From univariate analysis, the site of the tumor, the presence of teeth within the PTV and acute mucositis correlated with the development of maxillary ORN. V(D) were significantly higher for all the dose levels tested in patients with maxillary ORN than patients without necrosis, according to both radiobiological models. The multivariate analysis showed that V60 significantly correlated with ORN risk. CONCLUSION: The volume of maxilla irradiated with high dose values was relevant for ORN development in our cohort of ACC patients. These results are in line with previously published data obtained with a different radiobiological model. Our findings might be helpful to prevent the risk of ORN in patients receiving CIRT. |
format | Online Article Text |
id | pubmed-8924362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89243622022-03-17 Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy Vischioni, Barbara Russo, Stefania Meuli, Martino Bonora, Maria Ronchi, Sara Ingargiola, Rossana Camarda, Anna Maria Imparato, Sara Preda, Lorenzo Ciocca, Mario Molinelli, Silvia Orlandi, Ester Front Oncol Oncology BACKGROUND: The present study aims to evaluate dosimetric and clinical risk factors for the development of maxillary osteoradionecrosis (ORN) in head and neck adenoid cystic carcinoma (ACC) patients treated with carbon ion radiotherapy (CIRT). METHODS: Clinical data and treatment plans of ACC patients, consecutively treated from January 2013 to September 2016 within the phase II clinical trial CNAO S9/2012/C, were retrospectively reviewed. ORN and other treatment-related toxicity were graded according to the Common Terminology Criteria for Adverse Events (CTACE), version 4.0. The maxillary bone was contoured on the planning CT, and only patients receiving more than 10% of the prescription dose at their maxilla were considered for the analysis (67 patients). The volumes of maxilla receiving doses from 10 Gy (RBE) to 60 Gy (RBE) (V(D)), with an increment of 10 Gy (RBE), and additional clinical factors were correlated to the incidence of ORN with univariate analysis (Chi-square test). The logistic regression model was subsequently applied for multivariate analysis. Treatment plans calculated with a local effect model (LEM)-based optimization were recalculated with the modified microdosimetric kinetic model (MKM), and compared with literature data from the Japanese experience. RESULTS: The median time interval from the start of CIRT to ORN appearance was 24 months (range, 8–54 months). Maxillary ORN was observed in 11 patients (16.4%). Grade 1 ORN was observed in 2 patients (18.1%), G2 in 4 (36.3%), G3 in 4 (36.3%) and G4 in 1 (9.3%). From univariate analysis, the site of the tumor, the presence of teeth within the PTV and acute mucositis correlated with the development of maxillary ORN. V(D) were significantly higher for all the dose levels tested in patients with maxillary ORN than patients without necrosis, according to both radiobiological models. The multivariate analysis showed that V60 significantly correlated with ORN risk. CONCLUSION: The volume of maxilla irradiated with high dose values was relevant for ORN development in our cohort of ACC patients. These results are in line with previously published data obtained with a different radiobiological model. Our findings might be helpful to prevent the risk of ORN in patients receiving CIRT. Frontiers Media S.A. 2022-03-02 /pmc/articles/PMC8924362/ /pubmed/35311095 http://dx.doi.org/10.3389/fonc.2022.829502 Text en Copyright © 2022 Vischioni, Russo, Meuli, Bonora, Ronchi, Ingargiola, Camarda, Imparato, Preda, Ciocca, Molinelli and Orlandi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Vischioni, Barbara Russo, Stefania Meuli, Martino Bonora, Maria Ronchi, Sara Ingargiola, Rossana Camarda, Anna Maria Imparato, Sara Preda, Lorenzo Ciocca, Mario Molinelli, Silvia Orlandi, Ester Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy |
title | Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy |
title_full | Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy |
title_fullStr | Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy |
title_full_unstemmed | Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy |
title_short | Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy |
title_sort | dosimetric and clinical risk factors for the development of maxillary osteoradionecrosis in adenoid cystic carcinoma (acc) patients treated with carbon ion radiotherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924362/ https://www.ncbi.nlm.nih.gov/pubmed/35311095 http://dx.doi.org/10.3389/fonc.2022.829502 |
work_keys_str_mv | AT vischionibarbara dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT russostefania dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT meulimartino dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT bonoramaria dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT ronchisara dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT ingargiolarossana dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT camardaannamaria dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT imparatosara dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT predalorenzo dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT cioccamario dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT molinellisilvia dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy AT orlandiester dosimetricandclinicalriskfactorsforthedevelopmentofmaxillaryosteoradionecrosisinadenoidcysticcarcinomaaccpatientstreatedwithcarbonionradiotherapy |